Transplant News and Research

RSS

Hana Biosciences reports net loss of $5M for fourth quarter 2009

Hana Biosciences Inc., a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the fourth quarter and year ended December 31, 2009, and provided a corporate update.

26 Mar 2010

New therapies increase survival rates in post-transplant liver cancer patients

A recent study found that sirolimus-based immunosuppression following liver transplantation in patients with non-resectable hepatocellular carcinoma (liver cancer) significantly increases survival rates for this patient population. Results of this study appear in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).

25 Mar 2010

Isotechnika Pharma releases fourth quarter financial results; reviews operational and scientific highlights for 2009

Isotechnika Pharma Inc. has released its financial results for the fourth quarter and year ended December 31, 2009 and provided a review of the Company's operational and scientific highlights for 2009

25 Mar 2010

Fertility remains a significant issue for majority of breast cancer patients

The use of chemotherapy and hormonal treatments in young women can have significant implications for their fertility.

24 Mar 2010

Gentium presents abstract on Defibrotide at EBMT Annual Meeting

Gentium S.p.A.today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicenter study," was presented on Sunday, March 21, 2010, at the opening session of the European Blood and Marrow Transplantation 36th Annual Meeting in Vienna. The abstract received the esteemed Van Bekkum Award for the best abstract submitted to the physician's program. Dr. Selim Corbacioglu, Professor of Pediatrics, University of Regensburg (Germany) and Principal Investigator of the Pediatric Prevention trial, accepted the award and presented the final results of the study.

24 Mar 2010

Optimism may be good for your health

Feeling better about the future might help you feel better for real. In a new study, psychological scientists Suzanne Segerstrom of the University of Kentucky and Sandra Sephton of the University of Louisville studied how law students' expectations about the future affected their immune response.

24 Mar 2010

Johns Hopkins Hospital completes 100th kidney transplant

Surgeons at The Johns Hopkins Hospital have successfully completed their 100th kidney swap — a procedure popularized here to enlarge the pool of kidneys available for donation and provide organs to patients who might have died waiting for them.

24 Mar 2010

Coalition of international health organizations oppose compensation for bone marrow donors

Voicing concern about the potential impact on patient and donor safety, nine leading international health organizations have formed a coalition to oppose compensating people who provide bone marrow for transplantation.

23 Mar 2010

Number of living donor organs decreased since 2004: Study

The number of living donor organs available for transplant has progressively declined over the past five years, according to a new study. In addition, the study showed that for the first time, organs from deceased donors decreased in 2008.

23 Mar 2010

Progressive decline in organ donations

22 Mar 2010

Scientists identify new growth factor that stimulates expansion of hematopoietic stem cells

Scientists at Duke University Medical Center have identified a new growth factor that stimulates the expansion and regeneration of hematopoietic (blood-forming) stem cells in culture and in laboratory animals. The discovery, appearing in the journal Nature Medicine, may help researchers overcome one of the most frustrating barriers to cellular therapy: the fact that stem cells are so few in number and so stubbornly resistant to expansion.

22 Mar 2010

Study: Older adults with chronic illness often struggle to manage several prescribed drugs at a time

People with chronic illness often struggle to manage several prescribed drugs at a time. It's overwhelming when the vials, bottles and inhalers bulge from your medicine cabinet and you're confused about which drug is which, or when to take what.

20 Mar 2010

Kidney donors and recipients favor exchange of personal health information before transplantation, but not physicians

Most kidney donors and recipients are in favor of exchanging personal health information that may influence success before scheduling a living organ donor transplant, while healthcare professionals are more reluctant, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

19 Mar 2010

Robertson Foundation commits $10.2M for Duke Medicine's cell therapy research

A $10.2 million commitment from the Robertson Foundation to create a state-of-the-art Translational Cell Therapy Center (TCTC) will advance Duke Medicine's pioneering cell therapy research and treatment programs for children and adults with cancer, cerebral palsy, stroke and brain injuries suffered at birth.

19 Mar 2010

Physician scientists present new findings on aspirin therapy, atrial fibrillation drug therapy and LVAD

Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left ventricular assist devices may play in weight reduction for obese patients with chronic end-stage heart failure who are considered for heart transplantation.

19 Mar 2010

Bone Biologics receives Notice of Allowance of patent claims that protects formation of cartilage by UCB-1

Bone Biologics, Inc. announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1). Additional claims cover the surgical application of the NELL 1 (UCB-1) protein by several delivery agents.

18 Mar 2010

California jury rules insurer should pay for out-of-state operation; Mass. probe shows insurers' payments can vary widely

The Los Angeles Times: "A Los Angeles jury concluded Monday that Anthem Blue Cross should cover the cost of an out-of-state liver transplant that a California man paid for after the insurer balked. In addition, the jury ordered Blue Cross to pay plaintiff Ephram Nehme's legal expenses, which could dwarf the $206,000 cost of the transplant. Blue Cross approved Nehme's liver transplant in late 2006, and he was on the waiting list at UCLA Medical Center.

17 Mar 2010

Researchers evaluate novel organ sharing system that could help save more lives

Saint Louis University's Center for Outcome Research has received a $1 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to review regional kidney and liver distribution in the United States and equalize the access to transplantation among patients with similar stages of organ failure across the country.

17 Mar 2010

Viron Therapeutics' VT-346 anti-TNF protein exhibits positive results in transgenic mouse model for arthritis

Viron Therapeutics Inc. announced that VT-346, an anti-TNF protein therapeutic, demonstrated positive results in a pivotal proof of concept study in the gold standard transgenic mouse model for arthritis. VT-346 achieved a statistically significant, dose dependent impact in this preclinical model of arthritis and prevented deterioration due to disease in terms of weight gain, arthritic score and pathology parameters. VT-346 had particularly strong protective effects on therapeutically-important bone and cartilage damage in this model.

16 Mar 2010

Cytheris study: rhIL-7 treatment restores T cell trafficking and improves survival in animal model of sepsis

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced publication of data from a preclinical study in a clinically relevant animal model of sepsis showing that recombinant human Interleukin-7 (rhIL-7) treatment not only restores T cell trafficking and function, but also translates into improved survival.

16 Mar 2010

Transplant News and Research

Hana Biosciences reports net loss of $5M for fourth quarter 2009

New therapies increase survival rates in post-transplant liver cancer patients

Isotechnika Pharma releases fourth quarter financial results; reviews operational and scientific highlights for 2009

Fertility remains a significant issue for majority of breast cancer patients

Gentium presents abstract on Defibrotide at EBMT Annual Meeting

Optimism may be good for your health

Johns Hopkins Hospital completes 100th kidney transplant

Coalition of international health organizations oppose compensation for bone marrow donors

Number of living donor organs decreased since 2004: Study

Progressive decline in organ donations

Scientists identify new growth factor that stimulates expansion of hematopoietic stem cells

Study: Older adults with chronic illness often struggle to manage several prescribed drugs at a time

Kidney donors and recipients favor exchange of personal health information before transplantation, but not physicians

Robertson Foundation commits $10.2M for Duke Medicine's cell therapy research

Physician scientists present new findings on aspirin therapy, atrial fibrillation drug therapy and LVAD

Bone Biologics receives Notice of Allowance of patent claims that protects formation of cartilage by UCB-1

California jury rules insurer should pay for out-of-state operation; Mass. probe shows insurers' payments can vary widely

Researchers evaluate novel organ sharing system that could help save more lives

Viron Therapeutics' VT-346 anti-TNF protein exhibits positive results in transgenic mouse model for arthritis

Cytheris study: rhIL-7 treatment restores T cell trafficking and improves survival in animal model of sepsis

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News